3D Printing ProcessesMedical

Sinterit Lisa used to demonstrate specific 3D printed drug tablets

Stay up to date with everything that is happening in the wonderful world of AM via our LinkedIn community.

The Centre for Innovation and Process Engineering Research (CIPER) has a worldwide reputation for the implementation of 3D printing technologies for the development of pharmaceutical dosage forms and medical devices. The Centre has attracted significant funding from industry and also EU Research Programs (e.g., INTERREG 2 Seas). Sinterit technology was used to optimize a wide range of pharmaceutical products in the form of tablets and was coupled with Hot Melt Extrusion for the engineering of SLS printable powders. By using a wide range of polymers, they were able to print tablets with immediate, controlled, and sustained release of drug products.

They were looking for a technology that can print extruded or granulated powders loaded with drug substances and that would not depend on the development of printable filaments. In addition, Sinterit helped to design and print tablets with complex geometries. More importantly, it allowed the printing of several pharmaceutical-grade polymers and produce tablets with drug amounts that were impossible to process with other techniques.

This technology gives the unlimited capacity to process any thermally stable drug substance. Another important advantage is that allows them to accurately print tablet doses with different drug strength in the same batch and thus developed personalized dosage forms according to the need of the patients.

The University of Greenwich bought Sinterit Solution in 2020 and they were able to print their designed structures within one month. The easy-to-use software is one of the major advantages of the technology. Also, the fact that they can control the powder amounts (very important for expensive drugs) and the processing parameters (e.g., environment temperature, bed temperature) makes the technology unique for their applications. The post-processing equipment was very helpful to produce tablets without any unbound powder.

The technology is cost-effective for the printing of pharmaceutical tablets as it reduces processing steps while it allows the printing of several tablets in the batch-to-batch process. Sinterit can be used for the R&D but also the printing of pharmaceutical products and more importantly for personalized dosage forms.

Research 2021
Ceramic AM Market Opportunities and Trends

This market study from 3dpbm Research provides an in-depth analysis and forecast of the ceramic additive ma...

Andrea Gambini

Andrea has always loved reading and writing. He started working in an editorial office as a sports journalist in 2008, then the passion for journalism and for the world of communication in general, allowed him to greatly expand his interests, leading to several years of collaborations with several popular online newspapers. Andrea then approached 3D printing, impressed by the great potential of this new technology, which day after the day pushed him to learn more and more about what he considers a real revolution that will soon be felt in many fields of our daily life.

Related Articles

Back to top button

We use cookies to give you the best online experience. By agreeing you accept the use of cookies in accordance with our cookie policy.

Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • PHPSESSID
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Accept all Services

STAY AHEAD

OF THE CURVE

Join industry leaders and receive the latest insights on what really matters in AM!

This information will never be shared with 3rd parties

I’ve read and accept the privacy policy.*

WELCOME ON BOARD!